Foghorn Therapeutics Inc. (NASDAQ:FHTX) Given Consensus Rating of “Buy” by Brokerages
Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eight research firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation, six have issued a buy recommendation and one has given a strong buy recommendation to the company. […]
Foghorn Therapeutics Inc. (NASDAQ:FHTX – Get Free Report) has been assigned a consensus recommendation of “Buy” from the eight research firms that are covering the stock, Marketbeat.com reports. One analyst has rated the stock with a hold recommendation, six have issued a buy recommendation and one has given a strong buy recommendation to the company. […]
